Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs SANOFI INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA SANOFI INDIA DISHMAN PHARMA/
SANOFI INDIA
 
P/E (TTM) x 30.0 22.8 131.5% View Chart
P/BV x 3.3 6.1 54.8% View Chart
Dividend Yield % 0.7 8.5 7.8%  

Financials

 DISHMAN PHARMA   SANOFI INDIA
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
SANOFI INDIA
Dec-21
DISHMAN PHARMA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs3749,300 4.0%   
Low Rs1297,344 1.8%   
Sales per share (Unadj.) Rs197.01,283.8 15.3%  
Earnings per share (Unadj.) Rs21.2410.1 5.2%  
Cash flow per share (Unadj.) Rs34.7439.0 7.9%  
Dividends per share (Unadj.) Rs2.00490.00 0.4%  
Avg Dividend yield %0.85.9 13.5%  
Book value per share (Unadj.) Rs179.9940.3 19.1%  
Shares outstanding (eoy) m80.7023.03 350.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.36.5 19.7%   
Avg P/E ratio x11.920.3 58.5%  
P/CF ratio (eoy) x7.319.0 38.3%  
Price / Book Value ratio x1.48.9 15.8%  
Dividend payout %9.4119.5 7.9%   
Avg Mkt Cap Rs m20,307191,661 10.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5,3554,339 123.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,89829,566 53.8%  
Other income Rs m265746 35.6%   
Total revenues Rs m16,16330,312 53.3%   
Gross profit Rs m4,10312,515 32.8%  
Depreciation Rs m1,091667 163.5%   
Interest Rs m94418 5,246.7%   
Profit before tax Rs m2,33412,576 18.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6243,132 19.9%   
Profit after tax Rs m1,7109,444 18.1%  
Gross profit margin %25.842.3 61.0%  
Effective tax rate %26.724.9 107.3%   
Net profit margin %10.831.9 33.7%  
BALANCE SHEET DATA
Current assets Rs m11,01836,791 29.9%   
Current liabilities Rs m9,51722,908 41.5%   
Net working cap to sales %9.447.0 20.1%  
Current ratio x1.21.6 72.1%  
Inventory Days Days57189 30.2%  
Debtors Days Days318 19.8%  
Net fixed assets Rs m18,78718,762 100.1%   
Share capital Rs m161230 70.2%   
"Free" reserves Rs m14,35421,425 67.0%   
Net worth Rs m14,51621,655 67.0%   
Long term debt Rs m4,1890-   
Total assets Rs m29,80555,553 53.7%  
Interest coverage x3.5699.7 0.5%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.50.5 100.2%   
Return on assets %8.917.0 52.3%  
Return on equity %11.843.6 27.0%  
Return on capital %17.558.2 30.1%  
Exports to sales %24.90-   
Imports to sales %3.719.4 19.3%   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m5945,723 10.4%   
Fx inflow Rs m4,9523,856 128.4%   
Fx outflow Rs m6975,723 12.2%   
Net fx Rs m4,255-1,867 -227.9%   
CASH FLOW
From Operations Rs m2,7865,588 49.9%  
From Investments Rs m-1,5296,308 -24.2%  
From Financial Activity Rs m-941-8,490 11.1%  
Net Cashflow Rs m3173,406 9.3%  

Share Holding

Indian Promoters % 61.4 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 23.0 26.5 86.5%  
FIIs % 12.0 8.3 144.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 39.6 97.5%  
Shareholders   52,291 73,734 70.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on Dishman Pharma vs Sanofi India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Sanofi India Share Price Performance

Period Dishman Pharma Sanofi India S&P BSE HEALTHCARE
1-Day 2.87% 0.95% -0.10%
1-Month -2.45% 1.93% -1.99%
1-Year 96.38% -27.25% -5.62%
3-Year CAGR 50.28% -7.13% 20.96%
5-Year CAGR 41.17% 5.54% 11.47%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Sanofi India share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Sanofi India the stake stands at 60.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Sanofi India.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Sanofi India paid Rs 490.0, and its dividend payout ratio stood at 119.5%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Sanofi India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.